Neuronetics, Inc.

Equities

STIM

US64131A1051

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-24 pm EST			5-day change	1st Jan Change
2.440 ^USD	+2.09%		-0.81%	+51.55%

Jan. 13	Neuronetics, Inc. Announces Unaudited Revenue Results for Fourth Quarter and Full Year 2024	CI
Jan. 13	Neuronetics, Inc. Provides Earnings Guidance for the Full Year 2025	CI

Neuronetics, Inc., Q2 2024 Earnings Call, Aug 12, 2024

August 12, 2024 at 08:30 am EDT

Presentation Operator Message
Operator (Operator)

Good day, and thank you for standing by. Welcome to the Neuronetics Second Quarter 2024 Financial and Operating Results Conference Call. [Operator

This article is reserved for subscribers

To unlock the article, SUBSCRIBE!

Already a customer? Log In

Latest news about Neuronetics, Inc.

Neuronetics, Inc. Announces Unaudited Revenue Results for Fourth Quarter and Full Year 2024	Jan. 13	CI
Neuronetics, Inc. Provides Earnings Guidance for the Full Year 2025	Jan. 13	CI
Neuronetics, Inc. completed the acquisition of Greenbrook TMS Inc. (OTCPK:GBNH.F) from Madryn Health Partners II (Cayman Feeder), LP, fund managed by Madryn Asset Management, LP, 1315 Capital II, L.P. fund managed by 1315 Capital, LLC, Greybrook Health Inc. and others for $0.58 million.	Dec. 08	CI
Neuronetics, Inc., Q3 2024 Earnings Call, Nov 12, 2024	Nov. 12
Earnings Flash (STIM) NEURONETICS Reports Q3 Revenue $18.5M	Nov. 12	MT
Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	Nov. 12	CI
Neuronetics, Inc. Provides Standalone Earnings Guidance for the Fourth Quarter and Full Year 2024	Nov. 12	CI
Neuronetics, Greenbrook Receive Interim Order for Special Meeting of Shareholders for Greenbrook	24-10-04	MT
Neuronetics, Inc. Expands Health Policies Enhance Tms Therapy Access for Adolescents and Adults	24-09-19	CI
William Blair Downgrades Neuronetics to Market Perform From Outperform	24-08-13	MT
Neuronetics Shares Slump as Q2 Results Fall Below Estimates; Merger Announcement	24-08-12	MT
Neuronetics, Inc., Q2 2024 Earnings Call, Aug 12, 2024	24-08-12
Neuronetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	24-08-12	CI
Earnings Flash (STIM) NEURONETICS Reports Q2 Revenue $16.5M, vs. Street Est of $18.7M	24-08-12	MT
Neuronetics, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2024	24-08-12	CI
Neuronetics, Inc. entered into a definitive arrangement agreement to acquire Greenbrook TMS Inc. (OTCPK:GBNH.F) from Madryn Health Partners II (Cayman Feeder), LP, fund managed by Madryn Asset Management, LP and others for $1 million.	24-08-11	CI
Neuronetics, Inc. Announces Aetna Policy Update Expands TMS Availability for Adolescents with Depression	24-07-22	CI
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents	24-05-15	CI
William Blair Upgrades Neuronetics to Outperform From Market Perform	24-05-14	MT
Neuronetics, Inc., Q1 2024 Earnings Call, May 07, 2024	24-05-07
Earnings Flash (STIM) NEURONETICS Reports Q1 Revenue $17.4M	24-05-07	MT
Neuronetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-05-07	CI
Neuronetics, Inc. Provides Earnings Guidance for the Second Quarter of Fiscal Year 2024	24-05-07	CI
Neuronetics, Inc. Announces the Publication of Significant Clinical Findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation	24-04-10	CI
Neuronetics, Inc. Announces John K. Bakewell, Joseph H. Capper and Dr. Wilfred E. Jaeger Not Stand for Reelection to the Board	24-03-28	CI